1,330 results on '"Simrén, Magnus"'
Search Results
2. Coffee, Alcohol, and Artificial Sweeteners Have Temporal Associations with Gastrointestinal Symptoms
3. Effect of Brain-Gut Behavioral Treatments on Abdominal Pain in Irritable Bowel Syndrome: Systematic Review and Network Meta-Analysis
4. Association Between Celiac Disease and Irritable Bowel Syndrome: A Nationwide Cohort Study
5. A low FODMAP diet plus traditional dietary advice versus a low-carbohydrate diet versus pharmacological treatment in irritable bowel syndrome (CARIBS): a single-centre, single-blind, randomised controlled trial
6. Prolonged Gastrointestinal Manifestations After Recovery From COVID-19
7. Quality of Life and Bidirectional Gut-Brain Interactions in Irritable Bowel Syndrome From Adolescence to Adulthood
8. The influence of muscle performance and fatigue on prognosis in patients with compensated liver disease
9. Genome-wide multi-trait analysis of irritable bowel syndrome and related mental conditions identifies 38 new independent variants
10. The alternative serotonin transporter promoter P2 impacts gene function in females with irritable bowel syndrome
11. Factor Analysis of the Rome IV Criteria for Major Disorders of Gut-Brain Interaction (DGBI) Globally and Across Geographical, Sex, and Age Groups
12. The serotonin receptor 3E variant is a risk factor for female IBS-D
13. Mechanisms underlying food-related symptoms in disorders of gut-brain interaction: Course ahead in research and clinical practice
14. Treatments targeting the luminal gut microbiota in patients with irritable bowel syndrome
15. Quality of life in irritable bowel syndrome: Exploring mediating factors through structural equation modelling
16. Functional Gastrointestinal Disorders and Associated Health Impairment in Individuals with Celiac Disease
17. Food Avoidance and Restriction in Irritable Bowel Syndrome: Relevance for Symptoms, Quality of Life and Nutrient Intake
18. Greater Overlap of Rome IV Disorders of Gut-Brain Interactions Leads to Increased Disease Severity and Poorer Quality of Life
19. Global Prevalence and Impact of Rumination Syndrome
20. Global prevalence and burden of meal-related abdominal pain
21. Maintaining work life under threat of symptoms: a grounded theory study of work life experiences in persons with Irritable Bowel Syndrome
22. BPP43_05035 is aBrachyspira pilosicolicell surface adhesin that weakens the integrity of the epithelial barrier during infection
23. Targeting the gut microenvironment in IBS to improve symptoms
24. The placebo response rate in pharmacological trials in patients with irritable bowel syndrome: a systematic review and meta-analysis
25. Prevalence and Progression of Recurrent Abdominal Pain, From Early Childhood to Adolescence
26. Online Education Is Non-Inferior to Group Education for Irritable Bowel Syndrome: A Randomized Trial and Patient Preference Trial
27. The overlap between irritable bowel syndrome and organic gastrointestinal diseases
28. Rome IV Functional Gastrointestinal Disorders and Health Impairment in Subjects With Hypermobility Spectrum Disorders or Hypermobile Ehlers-Danlos Syndrome
29. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study
30. Diarrhoea of unknown cause : medical treatment in a stepwise manner: Management of Idiopathic Diarrhoea Based on Experience of Step-Up Medical Treatment
31. Relationship Between Abuse History and Gastrointestinal and Extraintestinal Symptom Severity in Irritable Bowel Syndrome
32. Exposure of Colon-Derived Epithelial Monolayers to Fecal Luminal Factors from Patients with Colon Cancer and Ulcerative Colitis Results in Distinct Gene Expression Patterns.
33. Predictors of Symptoms Trajectories in Newly Diagnosed Ulcerative Colitis: A 3-Year Follow-up Cohort Study.
34. Centrally Mediated Abdominal Pain Syndrome
35. Adherence to diet low in fermentable carbohydrates and traditional diet for irritable bowel syndrome
36. Fecal Incontinence Diagnosed by the Rome IV Criteria in the United States, Canada, and the United Kingdom
37. Worldwide population prevalence and impact of sub‐diagnostic gastrointestinal symptoms
38. Comments on the use of confocal laser endomicroscopy in diagnosing protein-losing enteropathy
39. Temporal stability of fecal metabolomic profiles in irritable bowel syndrome
40. Evidence-based and mechanistic insights into exclusion diets for IBS
41. Fecal microbiota dynamics during disease activity and remission in newly diagnosed and established ulcerative colitis
42. A novel stepwise integrative analysis pipeline reveals distinct microbiota-host interactions and link to symptoms in irritable bowel syndrome
43. Allergy-related diseases in childhood and risk for abdominal pain-related functional gastrointestinal disorders at 16 years—a birth cohort study
44. Diet and gut microbiome interactions of relevance for symptoms in irritable bowel syndrome
45. Clinical and Cost Effectiveness of Online Cognitive Behavioral Therapy in Children With Functional Abdominal Pain Disorders
46. Cumulative Effects of Psychologic Distress, Visceral Hypersensitivity, and Abnormal Transit on Patient-reported Outcomes in Irritable Bowel Syndrome
47. Epidemiology, Clinical Characteristics, and Associations for Rome IV Functional Nausea and Vomiting Disorders in Adults
48. Symptom profiles compatible with disorders of gut‐brain interaction (DGBI) in organic gastrointestinal diseases: A global population‐based study
49. Natural history of symptoms and prognostic information of the rapid drink challenge and solid bolus swallows in esophagogastric junction outflow obstruction defined by manometry
50. The aging gut: Symptoms compatible with disorders of gut‐brain interaction (DGBI) in older adults in the general population
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.